Abstract
Session presented on: Friday, July 26, 2013:
Background: Pituitary tumors may be present in 15-30% of the population and are classified by size ( <1cm or >1cm) and hormonal secretory activity (deficiency or excess). Sleep disturbance has been demonstrated in patients with large tumors but there is a paucity of information regarding sleep disturbance for small tumors. Such tumors have been presumed to be asymptomatic and treatment has been limited to replacement of pituitary hormonal deficiencies or hypersecretion. Clinically, patients report sleep disturbance, fatigue and motivational deficits. There are no data that correlate these symptoms and no longitudinal data that reflect the impact of biochemical replacement therapies on these dysfunctions.
Purpose: To determine patient perception and severity of sleep disturbance and fatigue and if these correlate to perceived motivational disturbance, tumor size and pituitary hormonal dysfunction in patients with pituitary tumors.
Methods: A total of sixty seven subjects ( 47F/20M) with pituitary tumors meeting criteria were asked to complete a 17 item questionnaire identifying and quantifying sleep disturbance, fatigue and motivational deficiencies on a 6 point Likert scale (no dysfunction to severe dysfunction). On average a moderate level of dysfunction was reported in each category.
Results: All dysfunctions were significantly correlated (p>.000). There was no significant gender difference in the perception of sleep and motivation dysfunction but females perceived more fatigue than males t(64) = 2.49 ( p=0.015). A significant correlation was found between sleep disturbance and multiple pituitary hormonal deficiencies (rs=.27, p= 0.027) and greater sleep disturbance correlated with patients with smaller tumors rs=.256, p=0.037.
Conclusion: Patients with small pituitary tumors (<1cm), without pituitary deficiencies, require evaluation and treatment for sleep disturbance with a particular focus on fatigue in women. Further understanding of the etiology of these dysfunctions is needed in order to develop appropriate therapies.
Sigma Membership
Non-member
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Sleep Disturbance, Fatigue, Pituitary Tumor
Recommended Citation
Yedinak, Christine G., "Correlation of patient perception of fatigue, sleep disturbance with motivation and pituitary hormonal deficiencies in patients with pituitary tumors" (2013). INRC (Congress). 34.
https://www.sigmarepository.org/inrc/2013/presentations_2013/34
Conference Name
24th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Prague, Czech Republic
Conference Year
2013
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Correlation of patient perception of fatigue, sleep disturbance with motivation and pituitary hormonal deficiencies in patients with pituitary tumors
Prague, Czech Republic
Session presented on: Friday, July 26, 2013:
Background: Pituitary tumors may be present in 15-30% of the population and are classified by size ( <1cm or>1cm) and hormonal secretory activity (deficiency or excess). Sleep disturbance has been demonstrated in patients with large tumors but there is a paucity of information regarding sleep disturbance for small tumors. Such tumors have been presumed to be asymptomatic and treatment has been limited to replacement of pituitary hormonal deficiencies or hypersecretion. Clinically, patients report sleep disturbance, fatigue and motivational deficits. There are no data that correlate these symptoms and no longitudinal data that reflect the impact of biochemical replacement therapies on these dysfunctions.
Purpose: To determine patient perception and severity of sleep disturbance and fatigue and if these correlate to perceived motivational disturbance, tumor size and pituitary hormonal dysfunction in patients with pituitary tumors.
Methods: A total of sixty seven subjects ( 47F/20M) with pituitary tumors meeting criteria were asked to complete a 17 item questionnaire identifying and quantifying sleep disturbance, fatigue and motivational deficiencies on a 6 point Likert scale (no dysfunction to severe dysfunction). On average a moderate level of dysfunction was reported in each category.
Results: All dysfunctions were significantly correlated (p>.000). There was no significant gender difference in the perception of sleep and motivation dysfunction but females perceived more fatigue than males t(64) = 2.49 ( p=0.015). A significant correlation was found between sleep disturbance and multiple pituitary hormonal deficiencies (rs=.27, p= 0.027) and greater sleep disturbance correlated with patients with smaller tumors rs=.256, p=0.037.
Conclusion: Patients with small pituitary tumors (<1cm), without pituitary deficiencies, require evaluation and treatment for sleep disturbance with a particular focus on fatigue in women. Further understanding of the etiology of these dysfunctions is needed in order to develop appropriate therapies.